Silverarc Capital Management as of June 30, 2024
Portfolio Holdings for Silverarc Capital Management
Silverarc Capital Management holds 70 positions in its portfolio as reported in the June 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Merus N V (MRUS) | 8.7 | $37M | 624k | 59.17 | |
| Nuvalent Inc-a (NUVL) | 8.3 | $35M | 466k | 75.86 | |
| Avidity Biosciences Ord (RNA) | 5.0 | $21M | 518k | 40.85 | |
| Urogen Pharma (URGN) | 4.4 | $19M | 1.1M | 16.78 | |
| Erasca (ERAS) | 4.4 | $18M | 7.8M | 2.36 | |
| Insmed Call Call Option | 4.0 | $17M | 250k | 67.00 | |
| Morphic Hldg (MORF) | 3.9 | $17M | 486k | 34.07 | |
| Akero Therapeutics (AKRO) | 3.5 | $15M | 625k | 23.46 | |
| Celldex Therapeutics Com New (CLDX) | 3.3 | $14M | 375k | 37.01 | |
| Intra Cellular Therapies (ITCI) | 3.1 | $13M | 192k | 68.49 | |
| Poseida Therapeutics I (PSTX) | 2.5 | $11M | 3.6M | 2.92 | |
| Cogent Biosciences (COGT) | 2.4 | $10M | 1.2M | 8.43 | |
| Insmed Com Par $.01 (INSM) | 2.2 | $9.4M | 140k | 67.00 | |
| Alnylam Pharmaceuticals (ALNY) | 2.1 | $8.7M | 36k | 243.00 | |
| Elutia Cl A Com (ELUT) | 1.9 | $8.0M | 1.6M | 4.96 | |
| Corbus Pharmaceuticals Hldgs Com New (CRBP) | 1.8 | $7.8M | 173k | 45.25 | |
| Oric Pharmaceuticals (ORIC) | 1.8 | $7.6M | 1.1M | 7.07 | |
| Syndax Pharmaceuticals (SNDX) | 1.8 | $7.6M | 370k | 20.53 | |
| Rhythm Pharmaceuticals (RYTM) | 1.8 | $7.6M | 185k | 41.06 | |
| C4 Therapeutics Com Stk (CCCC) | 1.6 | $6.7M | 1.4M | 4.62 | |
| Sarepta Therapeutics (SRPT) | 1.6 | $6.6M | 42k | 158.00 | |
| Kalvista Pharmaceuticals (KALV) | 1.6 | $6.6M | 561k | 11.78 | |
| Veracyte (VCYT) | 1.4 | $6.1M | 282k | 21.67 | |
| Abivax Sa Sponsored Ads (ABVX) | 1.4 | $6.0M | 456k | 13.22 | |
| Olema Pharmaceuticals (OLMA) | 1.4 | $5.9M | 547k | 10.82 | |
| Adc Therapeutics Sa SHS (ADCT) | 1.3 | $5.6M | 1.8M | 3.16 | |
| Helix Acquisition Corp Ii Cl A Ord Shs (HLXB) | 1.2 | $5.1M | 500k | 10.22 | |
| Mersana Therapeutics | 1.2 | $5.0M | 2.5M | 2.01 | |
| Gossamer Bio (GOSS) | 1.2 | $5.0M | 5.5M | 0.90 | |
| Tela Bio (TELA) | 1.1 | $4.7M | 1.0M | 4.70 | |
| Disc Medicine (IRON) | 1.1 | $4.6M | 101k | 45.07 | |
| Biogen Idec (BIIB) | 1.1 | $4.5M | 19k | 231.82 | |
| Verona Pharma Sponsored Ads (VRNA) | 1.0 | $4.4M | 305k | 14.46 | |
| Geron Corporation (GERN) | 1.0 | $4.2M | 999k | 4.24 | |
| Biohaven (BHVN) | 0.8 | $3.5M | 100k | 34.71 | |
| Longboard Pharmaceuticals In | 0.8 | $3.3M | 123k | 27.03 | |
| Praxis Precision Medicines I Com New (PRAX) | 0.7 | $2.8M | 67k | 41.36 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 0.7 | $2.8M | 71k | 39.27 | |
| Biodesix (BDSX) | 0.7 | $2.8M | 1.8M | 1.53 | |
| Mirum Pharmaceuticals (MIRM) | 0.6 | $2.7M | 79k | 34.19 | |
| Solid Biosciences Com New (SLDB) | 0.6 | $2.7M | 473k | 5.67 | |
| Perspective Therapeutics Com New (CATX) | 0.6 | $2.6M | 260k | 9.97 | |
| Cerus Corporation (CERS) | 0.6 | $2.6M | 1.5M | 1.76 | |
| Compugen Ord (CGEN) | 0.6 | $2.5M | 1.5M | 1.68 | |
| Trevi Therapeutics (TRVI) | 0.6 | $2.5M | 844k | 2.98 | |
| Kodiak Sciences (KOD) | 0.6 | $2.5M | 1.1M | 2.35 | |
| Jasper Therapeutics Com New (JSPR) | 0.6 | $2.5M | 110k | 22.70 | |
| Engene Holdings (ENGN) | 0.6 | $2.5M | 264k | 9.43 | |
| Wave Life Sciences SHS (WVE) | 0.6 | $2.5M | 496k | 4.99 | |
| Fulcrum Therapeutics (FULC) | 0.6 | $2.5M | 398k | 6.20 | |
| Evogene SHS | 0.5 | $2.0M | 3.1M | 0.65 | |
| Stoke Therapeutics (STOK) | 0.5 | $1.9M | 142k | 13.51 | |
| Macrogenics (MGNX) | 0.4 | $1.6M | 370k | 4.25 | |
| Modular Med Com New (MODD) | 0.3 | $1.4M | 900k | 1.58 | |
| Zura Bio Class A Ord Shs (ZURA) | 0.3 | $1.1M | 329k | 3.50 | |
| Tarsus Pharmaceuticals (TARS) | 0.3 | $1.1M | 40k | 27.18 | |
| Alx Oncology Hldgs Put Put Option | 0.2 | $1.0M | 168k | 6.03 | |
| Vyne Therapeutics (VYNE) | 0.2 | $921k | 467k | 1.97 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 0.2 | $870k | 100k | 8.70 | |
| 89bio (ETNB) | 0.2 | $739k | 92k | 8.01 | |
| Molecular Templates Com New (MTEMQ) | 0.2 | $717k | 624k | 1.15 | |
| Fractyl Health (GUTS) | 0.2 | $712k | 167k | 4.27 | |
| C4 Therapeutics Call Call Option | 0.2 | $693k | 150k | 4.62 | |
| Soleno Therapeutics (SLNO) | 0.1 | $612k | 15k | 40.80 | |
| Karyopharm Therapeutics | 0.1 | $485k | 559k | 0.87 | |
| Mersana Therapeutics Call Call Option | 0.1 | $338k | 168k | 2.01 | |
| Relmada Therapeutics (RLMD) | 0.1 | $298k | 99k | 3.00 | |
| Aligos Therapeutics | 0.1 | $229k | 656k | 0.35 | |
| Vaxcyte (PCVX) | 0.0 | $189k | 2.5k | 75.51 | |
| Rocket Pharmaceuticals *w Exp 09/02/202 (RCKTW) | 0.0 | $6.4k | 105k | 0.06 |